Puerarin sodium chloride injection

[Specification] 100ml:0.2g;250ml:0.4g;250ml:0.6g;100ml:0.2g

[Indications] Puerarin in sodium chloride injection contains puerarin, an isoflavone obtained from the root of Pueraria lobata, and is used in China as supportive treatment for ischaemic heart disease, including angina and myocardial infarction, for retinal artery and vein occlusion and sudden deafness, and in some formulations for ischaemic cerebrovascular disease.

[Usage and dosage] Administer by intravenous infusion. Adult doses used in China are 200 to 400 mg of puerarin once daily, diluted in 250 to 500 mL of infusion solution, with treatment courses usually lasting 10 to 20 days; the total cumulative dose should not exceed 5 g in patients over 65 years of age. Puerarin can cause fever, haemolysis and allergic reactions and is not authorised in the European Union or the United States.